More Than 100 Biotech Company Leaders Warn Trump Administration’s Travel Ban Could Hurt U.S. Leadership In Drug Research

The Hill: Drug researchers warn Trump’s travel ban will hurt anti-disease work
“More than 100 leaders in the biotech community warned President Trump that his travel ban could deeply damage U.S. leadership in the development of new medicines. In a letter published in Nature Biotech, a top scientific journal, founders and leaders of biotechnology companies expressed ‘deep concern and opposition’ to the travel ban, which bars citizens from seven majority-Muslim countries from entering the United States…” (Hellmann, 2/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.